VitalSigns
Return to the Blog Homepage

Tag Archives: pharma

June 27, 2016

0 Comments

Written by

Categories: Communications, Healthcare

Tags: , ,

How Can a Game of Chess Help Pharmaceutical Companies?

It seems like there isn’t a healthcare story written these days that doesn’t mention pricing. Even when a drug is facing review by the FDA Advisory Committee, somewhere, you’ll see a line about the potential Wholesale Acquisition Cost, or WAC....

The Week That Was: Crises in Healthcare Communications

  CONGRESS FIRES AT PHARMA The day we’ve all been waiting for did not disappoint. In fact, the rhetoric was fiery between Congressional committee members and pharmaceutical executives testifying at Thursday’s hearing on drug pricing. Convened by the Congressional Committee...

February 4, 2016

0 Comments

Written by

Categories: Advocacy

Tags: , ,

Sharing the Mission to Conquer Rare Disease

At an ever-quickening pace, biopharmaceutical companies and patient advocacy groups are banding together to hasten development of new drugs for rare diseases. These relationships bring tremendous value to both sides but also present challenges. Increasingly, patient groups want companies to...

January 25, 2016

0 Comments

Written by

Categories: Digital and Social Media, Facebook

Tags: ,

Lack of expertise limits pharma’s Facebook use

Regulatory is no longer the biggest hurdle for pharma when it comes to Facebook – it’s more about how to be relevant, credible and engaging. Our head of Digital & Social Strategy, Chris Iafolla, explains for MM&M: On August 24,...

August 24, 2015

0 Comments

Written by

Categories: Communications

Tags: , , , ,

Do No Harm: Avoid “Statistical Malpractice”

Communications and complex math are traditionally at odds, but the disciplines are merging now more than ever for healthcare communicators. We are charged on a daily basis with adding creativity and color to often the most banal, icky or complex...

July 1, 2015

0 Comments

Written by

Categories: Communications, Health

Tags: ,

Adapt or Die: What it Takes to Survive in Pharma

Charles Darwin once said, “It is not the strongest of the species that survive, nor the most intelligent, but the one more responsive to change.” This observation is brilliant in its simplicity. It speaks to the underlying primal need we...

June 30, 2015

0 Comments

Written by

Categories: Health Policy and Access

Tags: , ,

Beltway Buzz: June 2015

Who said summer was a time for relaxation? Between the highly anticipated SCOTUS decision and things shaking up in the pharma world, DC is full steam ahead.   The King Of All Decisions: In a long-awaited King vs. Burwell decision,...

June 25, 2015

0 Comments

Written by

Categories: Consumers, Health and Wellness

Tags: ,

What Can Pharma Learn From J&J and Sanofi About Reaching Millennials?

In a year when Millennials are projected to compose the majority of the workforce and overtake Baby Boomers as the largest living population, it’s time that healthcare brands start to look at them with an unbiased eye—an eye that looks...

May 6, 2015

0 Comments

Written by

Categories: Healthcare, Medical Devices and Diagnostics

Tags: , ,

Startups to Pharma Marketers: It’s Time to Think ‘Beyond the Pill’

Healthcare tech startups need ways to connect with pharma marketers to explore fruitful partnerships; in turn, in today’s competitive marketplace, pharma is constantly seeking for opportunities to exploit the latest tech advances to differentiate their offering. The inaugural MM&M Transforming...

September 8, 2014

0 Comments

Written by

Categories: Global Healthcare

Tags: , , , , ,

Ebola is Here

At the age of 12, I went through that typical stage in any young woman’s life when she becomes obsessed with all things infectious diseases – particularly ebola. From watching Outbreak on repeat and imagining I would one day be...